IONS vs ZION · rev $514.0M vs P/E 11, rev $354.0M
Ionis Pharmaceuticals Inc (IONS) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
IONS currently screens at market cap $12.28B. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the IONS and ZION stock pages for the full models.
Not investment advice.